SEI Investments
RARX

SEI Investments’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

SEI Investments’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,787
Closed -$420K – 2486
2019
Q3 		$420K Sell
17,787
-1,905
-10% -$56.5K ﹤0.01% 1977
2019
Q2 		$592K Sell
19,692
-2,772
-12% -$63.5K ﹤0.01% 1801
2019
Q1 		$504K Buy
+22,464
New +$483K ﹤0.01% 1884

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

SEI Investments's RARX Position: Q4 2019 in Review

SEI Investments sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q4 2019, closing a stake of 17,787 shares — an estimated $420K sold.

SEI Investments first reported a position in RARX in Q1 2019 and held it in 3 quarters. The position peaked at $592K in Q2 2019. 146 funds tracked by Wall St. Rank hold RARX as of Q4 2019.

  • SEI Investments reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • SEI Investments sold 17,787 Ra Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $420K.
  • SEI Investments first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • SEI Investments's Ra Pharmaceuticals, Inc. Common Stock position peaked at $592K in Q2 2019.
  • 146 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on SEI Investments's 13F filing for Q4 2019, filed 6 Feb 2020.